Organism | Odds ratio (95% CI) | Bivariate p-value | Multivariate logistic regression | Wald p-values |
---|---|---|---|---|
Enterobacteriaceae | Â | Â | Â | Â |
   Age < 1 year | 4.6 (2–11.1) | 0.0004 | 4.4 (1.9–10.9) | 0.0008 |
   Stage C disease | 3.7 (1.6–8.6) | 0.002 | 3.6 (1.5–8.6) | 0.005 |
   Female | 0.5 (0.23–1.19) | 0.13 |  |  |
   CDC Immunological Class 2 or 3 | 2 (0.7–6.9) | 0.23 |  |  |
   Weight for age-Z-score <-2 | 1.6 (0.7–3.5) | 0.27 |  |  |
No prior TMP-SMX at baseline | 0.3 (0.03–1.3) | 0.22 |  |  |
Present and/or previous hospitalization | 1.1 (0.4–3.7) | 0.9 |  |  |
S. aureus | 1 (0.3–3.8) | 1 |  |  |
   Age < 1 year | 1.2(0.6–2.4) | 0.6 |  |  |
   Stage C | 0.1 (0.6–2.9) | 0.4 |  |  |
   Weight for age-Z-score <-2 | 2 (1–3.9) | 0.051 | 1.7 (0.8–3.5) | 0.11 |
CDC Immunological Class 2 or 3 | 3.7 (1.4–12.9) | 0.007 | 3.4 (1.3–11.8) | 0.029 |
Female | 1.2 (0.63–2.4) | 0.54 |  |  |
No prior TMP-SMX at baseline | 0.97 (0.42–2.1) | 0.94 |  |  |
Present and/or previous hospitalization | 2.04 (0.8–6.3) | 0.14 |  |  |
S. pneumoniae | Â | Â | Â | Â |
   Age < 1 year | 0.53 (0.2–1.1) | 0.09 |  |  |
   Stage C | 0.51 (0.2–1.6) | 0.13 |  |  |
   Weight for age-Z-score <-2 | 0.71 (0.4–1.4) | 0.31 |  |  |
CDC Immunological Class 2 or 3 | 0.8 (0.4–1.6) | 0.5 |  |  |
Female | 0.97 (0.5–1.9) | 0.92 |  |  |
No prior TMP-SMX at baseline | 1.4 (0.4–5.3) | 0.67 |  |  |
Present and/or previous hospitalization | 0.64 (0.29–1.46) | 0.28 |  |  |
Gram-negative respiratory organisms | Â | Â | Â | Â |
   Age < 1 year | 0.53 (0.2–0.98) | 0.055 | 0.59 (0.24–1.33) | 0.22 |
   Stage C | 0.8 (0.3–1.7) | 0.51 |  |  |
   Weight for age-Z-score <-2 | 0.46 (0–0.9) | 0.029 | 0.55 (0.25–1.2) | 0.14 |
CDC Immunological Class 2 or 3 | 0.32 (0.16–0.66) | 0.002 | 0.33 (0.15–0.71) | 0.005 |
Female | 1.4 (0.75–2.8) | 0.28 |  |  |
No prior TMP-SMX at baseline | 5.1 (1.4–22.1) | 0.058 | 0.33 (0.09–0.94) | 0.057 |
Present and/or previous hospitalization | 0.5 (0.23–1.12) | 0.094 | 0.63 (0.27–1.54) | 0.3 |